Safety and efficacy of rivaroxaban versus warfarin in atrial fibrillation with stage 4 to 5 chronic kidney disease including dialysis
In patients with AF and advanced CKD including dialysis, rivaroxaban may be associated with improved efficacy and safety compared with warfarin. However, heterogeneity in CKD stages and off-label dosing practices necessitate prospective randomized trials to establish definitive treatment recommendations.
Authors
- Anwar Almajdi
- Sara Almutairi
- Maha Alharbi
Institutions
- Jahra Hospital (KW)
- Kuwait University (KW)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.rpth.2026.103398
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 30.07